Figures & data
Table 1 Type of pharmacological treatment among individuals with CBP stratified by demographic, socioeconomic and clinical characteristics, MEPS 2011–2015 (N=5,203)
Table 2 Factors associated with the likelihood of receiving NSAIDs only and combination of opioids and NSAIDs among individuals with CBP, MEPS 2011–2015 (N=5,203)
Figure 1 Comparison of HRQoL using SF-12v2 (PCS score and MCS score) between treatment groups: opioids only, NSAIDs only and combination of opioids and NSAIDs adjusted for all covariates.
Table 3 Multiple linear regression model for the comparison of PCS and MCS scores in individuals with CBP (N=5,203)
Figure 2 Comparison of mean adjusted cost between the three pharmacological treatment groups: opioids only, NSAIDs only and combination of opioids and NSAIDs adjusted for all covariates.
Figure S1 Flowchart detailing data extraction and sample selection.
Abbreviations: CBP, chronic back pain; ICD-9-CM, ICD, Ninth Revision, Clinical Modification; MCS, mental component summary; MEPS-HC, Medical Expenditure Panel Survey Household Component; PCS, physical component summary.
Table S1 Baseline characteristics of individuals with CBP (MEPS 2011–2015)
Table S2 Differences in health care utilization individuals utilizing opioids only, NSAIDs only and a combination of NSAIDs and opioids
Table S3 Generalized linear models: incremental effects of total health care expenditures among US adults diagnosed with CBP accounting for relevant covariates (adjusted to 2017 dollars)